Pregled po projektu: Farmaceutski otvorena ispitna platforma za nano-farmaceutske inovativne proizvode (Phoenix) (MB: EK-H2020-953110)
Pronađeno 3 radova
-
1.Ilić, Krunoslav; Drinković, Nikša; Debeljak, Željko; Micek, Vedran; Kalčec, Nikolina; Pavičić, Ivan; Tűreli, Emre; Gűnday Tűreli, Nazende; Vinković Vrček, IvanaDesign of novel nanoformulation to decrease cardiotoxicity of doxorubicin // Final CA17140 COST Conference Cancer Nanomedicine – from the Bench to the Bedside - Book of Abstracts
Rim, Italija, 2022. str. 21-21 (predavanje, međunarodna recenzija, pp prezentacija, znanstveni) -
2.Debeljak, Željko; Vinković Vrček, Ivana; Drinković, Nikša; Micek, Vedran, Galić, Emerik, Gorup, Dunja; Ćurlin, Marija; Mandić, Dario; Bandjak, Ana; Pem, Barbara; Kalčec, Nikolina; Ilić, Krunoslav et al.Imaging mass spectrometry differentiates the effects of doxorubicin formulations on non-targeted tissues // Analyst, 147 (2022), 3201-3208 doi:10.1039/D2AN00355D (međunarodna recenzija, članak, znanstveni)
-
3.Zorić, Lara; Drinković, Nikša; Micek, Vedran; Frkanec, Leo; Türeli, Akif Emre; Günday-Türeli, Nazende; Vinković Vrček, Ivana; Frkanec, RužaHigh-Throughput Method for the Simultaneous Determination of Doxorubicin Metabolites in Rat Urine after Treatment with Different Drug Nanoformulations // Molecules, 27 (2022), 4; 1177, 14 doi:10.3390/molecules27041177 (međunarodna recenzija, članak, znanstveni)
